(Q38695989)

English

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

atrial fibrillation

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

venous thromboembolism

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

S Kaatz

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

D Ahmad

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

A C Spyropoulos

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Subcommittee on Control of Anticoagulation

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

1 November 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

2119-2126

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26764429%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Rivaroxaban for thromboprophylaxis in acutely ill medical patients

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Apixaban in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Safety and efficacy of the oral direct factor xa inhibitor apixaban in Japanese patients with non-valvular atrial fibrillation. -The ARISTOTLE-J study-.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Edoxaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Oral rivaroxaban for symptomatic venous thromboembolism

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Dabigatran versus warfarin in the treatment of acute venous thromboembolism

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Oral apixaban for the treatment of acute venous thromboembolism

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism

1 reference

https://api.crossref.org/works/10.1111%2FJTH.13140

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38695989&oldid=1506999911"